Holen Sie sich die Stockscreener-App
57.68
3.04%
-1.81
Handel nachbörslich:
57.68
Schlusskurs vom Vortag:
$59.49
Offen:
$60
24-Stunden-Volumen:
502.89K
Relative Volume:
0.91
Marktkapitalisierung:
$1.65B
Einnahmen:
$86.93M
Nettoeinkommen (Verlust:
$-1.48M
KGV:
-813.54
EPS:
-0.0709
Netto-Cashflow:
$431.00K
1W Leistung:
+3.93%
1M Leistung:
-8.52%
6M Leistung:
+141.95%
1J Leistung:
+186.40%
1-Tages-Spanne:
$57.23
$60.60
1-Wochen-Bereich:
$53.60
$60.60
52-Wochen-Spanne:
$14.27
$66.37
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Firmenname
Eton Pharmaceuticals Inc
Sektor
Telefon
(847) 787-7361
Adresse
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, TEVA, HLN, ZTS, VTRS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
57.68 | 1.65B | 86.93M | -1.48M | 431.00K | -0.0709 |
TAK
Takeda Pharmaceutical Co Adr
|
18.86 | 60.23B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.19 | 45.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.26 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
71.05 | 29.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
VTRS
Viatris Inc
|
17.83 | 20.48B | 14.57B | -296.50M | 1.64B | -0.259 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-23 | Bestätigt | H.C. Wainwright | Buy |
| 2025-01-10 | Eingeleitet | B. Riley Securities | Buy |
| 2025-01-06 | Bestätigt | H.C. Wainwright | Buy |
| 2024-09-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-05-06 | Eingeleitet | Craig Hallum | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-01-04 | Bestätigt | H.C. Wainwright | Buy |
| 2019-09-20 | Eingeleitet | B. Riley FBR | Buy |
| 2019-06-10 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Eton Pharmaceuticals Inc Aktie (ETON) Neueste Nachrichten
Understanding Momentum Shifts in (ETON) - Stock Traders Daily
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Eton Pharmaceuticals stock gains 6.98 percent after Q2 results - AD HOC NEWS
Is Eton Pharmaceuticals Inc (ETON) Overvalued After 7.0% Rally? - GuruFocus
Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Up 5.9%Should You Buy? - MarketBeat
ETON Stock Price, Quote & Chart - ChartMill
Eton Pharmaceuticals stock reports 99 percent Q2 revenue growth - AD HOC NEWS
Eton Pharmaceutcials (ETON) Stock Price, News & Analysis - Stock Titan
Eton Pharmaceuticals stock edges higher after strong 2025 growth figures - AD HOC NEWS
Eton Pharmaceuticals stock holds steady as insider sales and recent results shape the picture - AD HOC NEWS
Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Unveiling a 24.41% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Eton Pharmaceuticals stock holds steady as investors eye latest results - AD HOC NEWS
Liquidity Mapping Around (ETON) Price Events - Stock Traders Daily
Squarepoint Ops LLC Invests $2.16 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
HighTower Advisors LLC Acquires 34,484 Shares of Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Hsbc Holdings PLC Makes New $1.53 Million Investment in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (ETON) Heads To Wells Fargo Conference As Fair Value Debate Stays Open - simplywall.st
Eton Pharmaceuticals Inc (NASDAQ: ETON) Share Price, ETON Stock News, ETON Share Price & Updates - Kalkine
118,249 Shares in Eton Pharmaceuticals, Inc. $ETON Purchased by Bank of New York Mellon Corp - MarketBeat
(ETON) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
ETON stock holds firm after latest quarter shows steady growth - AD HOC NEWS
Sigma Planning Corp Takes Position in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
PAUL MAIER V At Eton Pharmaceuticals Executes Options Exercise, Realizing $2.84M - Benzinga
Hsbc Holdings PLC Invests $1.53 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals Q2 2026 Earnings: EPS Soars Past Estimates on Strong Operational ExecutionOperating Income Trends - careplusvn.com
Eton Pharmaceuticals Director Paul V. Maier Executes Stock Options and Sells Shares on August 28, 2026 - Kalkine Media
Eton Pharmaceuticals (ETON) director unloads 50K shares after option exercise - Stock Titan
34,027 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Jefferies Financial Group Inc. - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Deutsche Bank AG Purchases Shares of 26,522 Eton Pharmaceuticals, Inc. $ETON - MarketBeat
BlackRock Inc. Invests $68.63 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (ETON) Slips 1.74% as Shares Pull Back Toward Key SupportPrice Action Signals - dars.gov.et
Navellier & Associates Inc. Makes New Investment in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals, Inc. $ETON Stock Holdings Increased by Bank of America Corp DE - MarketBeat
1,175,951 Shares in Eton Pharmaceuticals, Inc. $ETON Purchased by Nantahala Capital Management LLC - MarketBeat
Cannell Capital LLC Acquires New Stake in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Director Sells $2,953,500.00 in Stock - MarketBeat
Eton Pharmaceuticals (NASDAQ: ETON) insider sells 50K shares - Stock Titan
Bank of Nova Scotia Acquires New Position in Eton Pharmaceuticals, Inc. $ETON - marketbeat.com
Eton leaders will hold one-on-one meetings at Wells Fargo’s Boston event - stocktitan.net
Pillsbury Lake Capital LLC Invests $14.02 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference - Yahoo Finance
Eton's Galzin TM And False Ad Suit Survives Dismissal Bid - Law360
Eton Pharmaceuticals Can Proceed With ‘Gluzin’ Supplement Suit - Bloomberg Law News
Insider Unloading: David Krempa Sells Options, Realizes $1.43MEton Pharmaceuticals (NASDAQ:ETON) - Benzinga
Eton Pharmaceuticals stock hits all-time high at 64.29 USD By Investing.com - Investing.com India
Eton (ETON) Financial Results: The Bottom-Line Figure Outpaces Its Comparison for the Current Session; Post-Report: Shares Move 5.94% UpDividend Cut Risk - vinanet.vn
Eton Pharmaceuticals (ETON) Returns To Profit As Valuation Debate Gets Harder To Ignore - Sahm
Eton Pharmaceuticals Inc (ETON) Stock Up 5.9% but GF Value Says Overvalued -- GF Score: 58/100 - GuruFocus
SEAN BRYNJELSEN Executes Sell Order: Offloads $6.09M In Eton Pharmaceuticals Stock - Benzinga
Eton Pharmaceuticals CEO Sean Brynjelsen sells $6.08m in stock By Investing.com - Investing.com India
Finanzdaten der Eton Pharmaceuticals Inc-Aktie (ETON)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):